Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
SorCS2-mediated NR2A trafficking regulates motor deficits in Huntington’s disease
Qian Ma, Jianmin Yang, Teresa A. Milner, Jean-Paul G. Vonsattel, Mary Ellen Palko, Lino Tessarollo, Barbara L. Hempstead
Qian Ma, Jianmin Yang, Teresa A. Milner, Jean-Paul G. Vonsattel, Mary Ellen Palko, Lino Tessarollo, Barbara L. Hempstead
View: Text | PDF
Research Article Neuroscience

SorCS2-mediated NR2A trafficking regulates motor deficits in Huntington’s disease

  • Text
  • PDF
Abstract

Motor dysfunction is a prominent and disabling feature of Huntington’s disease (HD), but the molecular mechanisms that dictate its onset and progression are unknown. The N-methyl-D-aspartate receptor 2A (NR2A) subunit regulates motor skill development and synaptic plasticity in medium spiny neurons (MSNs) of the striatum, cells that are most severely impacted by HD. Here, we document reduced NR2A receptor subunits on the dendritic membranes and at the synapses of MSNs in zQ175 mice that model HD. We identify that SorCS2, a vacuolar protein sorting 10 protein–domain (VPS10P-domain) receptor, interacts with VPS35, a core component of retromer, thereby regulating surface trafficking of NR2A in MSNs. In the zQ175 striatum, SorCS2 is markedly decreased in an age- and allele-dependent manner. Notably, SorCS2 selectively interacts with mutant huntingtin (mtHTT), but not WT huntingtin (wtHTT), and is mislocalized to perinuclear clusters in striatal neurons of human HD patients and zQ175 mice. Genetic deficiency of SorCS2 accelerates the onset and exacerbates the motor coordination deficit of zQ175 mice. Together, our results identify SorCS2 as an interacting protein of mtHTT and demonstrate that impaired SorCS2-mediated NR2A subunit trafficking to dendritic surface of MSNs is, to our knowledge, a novel mechanism contributing to motor coordination deficits of HD.

Authors

Qian Ma, Jianmin Yang, Teresa A. Milner, Jean-Paul G. Vonsattel, Mary Ellen Palko, Lino Tessarollo, Barbara L. Hempstead

×

Figure 5

SorCS2 interacts with mutant huntingtin and is mislocalized in human HD caudate and mouse HD striatum.

Options: View larger image (or click on image) Download as PowerPoint
SorCS2 interacts with mutant huntingtin and is mislocalized in human HD ...
(A) Co-IP of mutant huntingtin, but not WT huntingtin, with SorCS2 using anti-SorCS2 antibody and mouse striatal lysates. This protein interaction is detected in lysates of mice at 1 and 12 months of age. Three independent experiments were conducted. Ctrl, control experiment using zQ175/+ tissue but without anti-SorCS2 antibody; 1m, 1-month-old; 12m, 12-month-old; Q/+, zQ175/+ mice. (B) Immunohistochemical detection of SorCS2 in the caudate of grade 3 human HD patients (n = 3) and controls (n = 2). In control cases (left panel), SorCS2 is diffusely stained in the somatodendritic compartment of a subset of caudate neurons. However, in HD patients (right panel), localization of SorCS2 is mainly present in perinuclear clusters in neurons of the caudate. Scale bars: 20 μm. Pictures in the top right corners are enlarged images of neurons in the small red boxes. Scale bars of inset panels: 10 μm. (C) Immunofluorescence detection of SorCS2 in the striatum of WT (left panel) and zQ175 homozygous mice (right panel) at the age of 12 months. Scale bars: 20 μm. Note the reduction of SorCS2 immunoreactivity and its mislocalization to perinuclear clusters in a subset of neurons in the striatum of zQ175 homozygous mice. n = 3 animals/genotype. Pictures in the top right corners are enlarged images of neurons in the small white boxes. Scale bars of inset panels: 10 μm. (D) Statistical analysis of the percentage of caudate neurons in human sections that exhibit diffuse (Diff) or aggregated (Agg) staining of SorCS2. n = 3 for human grade 3 HD cases; n = 2 for human control cases; **P < 0.01; unpaired 2-tailed student t test. Data are presented as mean ± SEM. (E) Statistical analysis of the percentage of striatal neurons in mouse sections that exhibit Diff or Agg staining of SorCS2. n = 3 animals/genotype; *P < 0.05; **P < 0.01; unpaired 2-tailed student t test. Data are presented as mean ± SEM.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts